Frank Peters - Publications

Affiliations: 
Industrial and Manufacturing Systems Engineering Iowa State University, Ames, IA, United States 
Area:
Industrial Engineering

0/177 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
Low-probability matches (unlikely to be authored by this person)
2017 Voelker MM, Peters F. Development of a Digital Standard to Specify Surface Requirements of Cast Metal Surfaces Materials Performance and Characterization. 6: 130-143. DOI: 10.1520/Mpc20160014  0.231
2010 Sharma R, Molian P, Peters F. Geometric variability and surface finish of weld zones in Yb:YAG laser welded advanced high strength steels Journal of Manufacturing Processes. 12: 73-84. DOI: 10.1016/J.Jmapro.2010.05.001  0.212
2001 Voorhis TV, Peters F, Johnson D. Developing software for generating pouring schedules for steel foundries Computers & Industrial Engineering. 39: 219-234. DOI: 10.1016/S0360-8352(01)00003-1  0.211
2003 Peters FT, Schaefer S, Staack RF, Kraemer T, Maurer HH. Screening for and validated quantification of amphetamines and of amphetamine- and piperazine-derived designer drugs in human blood plasma by gas chromatography/mass spectrometry. Journal of Mass Spectrometry : Jms. 38: 659-76. PMID 12827635 DOI: 10.1002/jms.483  0.201
2010 Meyer MR, Wilhelm J, Peters FT, Maurer HH. Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography-mass spectrometry. Analytical and Bioanalytical Chemistry. 397: 1225-33. PMID 20333362 DOI: 10.1007/s00216-010-3636-5  0.2
2005 Ewald AH, Peters FT, Weise M, Maurer HH. Studies on the metabolism and toxicological detection of the designer drug 4-methylthioamphetamine (4-MTA) in human urine using gas chromatography-mass spectrometry. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 824: 123-31. PMID 16027051 DOI: 10.1016/j.jchromb.2005.07.007  0.2
2003 Springer D, Peters FT, Fritschi G, Maurer HH. New designer drug 4'-methyl-alpha-pyrrolidinohexanophenone: studies on its metabolism and toxicological detection in urine using gas chromatography-mass spectrometry. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 789: 79-91. PMID 12726846 DOI: 10.1016/S1570-0232(03)00043-6  0.192
2002 Springer D, Peters FT, Fritschi G, Maurer HH. Studies on the metabolism and toxicological detection of the new designer drug 4'-methyl-alpha-pyrrolidinopropiophenone in urine using gas chromatography-mass spectrometry. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 773: 25-33. PMID 12015267 DOI: 10.1016/S1570-0232(01)00578-5  0.192
2008 Sauer C, Peters FT, Staack RF, Fritschi G, Maurer HH. Metabolism and toxicological detection of a new designer drug, N-(1-phenylcyclohexyl)propanamine, in rat urine using gas chromatography-mass spectrometry. Journal of Chromatography. A. 1186: 380-90. PMID 18035363 DOI: 10.1016/j.chroma.2007.11.002  0.192
2014 Remane D, Wetzel D, Peters FT. Development and validation of a liquid chromatography-tandem mass spectrometry (LC-MS/MS) procedure for screening of urine specimens for 100 analytes relevant in drug-facilitated crime (DFC). Analytical and Bioanalytical Chemistry. 406: 4411-24. PMID 24817357 DOI: 10.1007/s00216-014-7841-5  0.191
2008 Sauer C, Peters FT, Staack RF, Fritschi G, Maurer HH. Metabolism and toxicological detection of the designer drug N-(1-phenylcyclohexyl)-3-methoxypropanamine (PCMPA) in rat urine using gas chromatography-mass spectrometry. Forensic Science International. 181: 47-51. PMID 18922655 DOI: 10.1016/j.forsciint.2008.09.001  0.188
2017 Barnawal P, Dorneich MC, Frank MC, Peters F. Evaluation of Design Feedback Modality in Design for Manufacturability Journal of Mechanical Design. 139: 94503. DOI: 10.1115/1.4037109  0.187
2008 Sauer C, Peters FT, Staack RF, Fritschi G, Maurer HH. New designer drugs N-(1-phenylcyclohexyl)-2-ethoxyethanamine (PCEEA) and N-(1-phenylcyclohexyl)-2-methoxyethanamine (PCMEA): Studies on their metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques. Journal of Mass Spectrometry : Jms. 43: 305-16. PMID 17968862 DOI: 10.1002/jms.1312  0.186
2005 Peters FT, Meyer MR, Fritschi G, Maurer HH. Studies on the metabolism and toxicological detection of the new designer drug 4'-methyl-alpha-pyrrolidinobutyrophenone (MPBP) in rat urine using gas chromatography-mass spectrometry. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 824: 81-91. PMID 16046201 DOI: 10.1016/j.jchromb.2005.07.003  0.186
2009 Peters FT, Dragan CA, Schwaninger AE, Sauer C, Zapp J, Bureik M, Maurer HH. Use of fission yeast heterologously expressing human cytochrome P450 2B6 in biotechnological synthesis of the designer drug metabolite N-(1-phenylcyclohexyl)-2-hydroxyethanamine. Forensic Science International. 184: 69-73. PMID 19135815 DOI: 10.1016/j.forsciint.2008.12.001  0.181
2007 Mueller M, Peters FT, Ricaurte GA, Maurer HH. Validated liquid chromatographic-electrospray ionization mass spectrometric assay for simultaneous determination of 3,4-methylenedioxymethamphetamine and its metabolites 3,4-methylenedioxyamphetamine, 3,4-dihydroxymethamphetamine, and 4-hydroxy-3-methoxymethamphetamine in squirrel monkey plasma. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 855: 262-70. PMID 17646137 DOI: 10.1016/j.jchromb.2007.06.034  0.176
2005 Beyer J, Bierl A, Peters FT, Maurer HH. Screening procedure for detection of diuretics and uricosurics and/or their metabolites in human urine using gas chromatography-mass spectrometry after extractive methylation. Therapeutic Drug Monitoring. 27: 509-20. PMID 16044110 DOI: 10.1097/01.ftd.0000160719.96445.91  0.175
2009 Peters FT, Dragan CA, Kauffels A, Schwaninger AE, Zapp J, Bureik M, Maurer HH. Biotechnological synthesis of the designer drug metabolite 4'-hydroxymethyl-alpha-pyrrolidinohexanophenone in fission yeast heterologously expressing human cytochrome P450 2D6--a versatile alternative to multistep chemical synthesis. Journal of Analytical Toxicology. 33: 190-7. PMID 19470220 DOI: 10.1093/JAT/33.4.190  0.174
2003 Kratzsch C, Peters FT, Kraemer T, Weber AA, Maurer HH. Screening, library-assisted identification and validated quantification of fifteen neuroleptics and three of their metabolites in plasma by liquid chromatography/mass spectrometry with atmospheric pressure chemical ionization. Journal of Mass Spectrometry : Jms. 38: 283-95. PMID 12644990 DOI: 10.1002/jms.440  0.171
2009 Sauer C, Peters FT, Haas C, Meyer MR, Fritschi G, Maurer HH. New designer drug alpha-pyrrolidinovalerophenone (PVP): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques. Journal of Mass Spectrometry : Jms. 44: 952-64. PMID 19241365 DOI: 10.1002/jms.1571  0.171
2012 Martínez-Ramírez JA, Voigt K, Peters FT. Studies on the metabolism of five model drugs by fungi colonizing cadavers using LC-ESI-MS/MS and GC-MS analysis. Analytical and Bioanalytical Chemistry. 404: 1339-59. PMID 22825674 DOI: 10.1007/s00216-012-6212-3  0.171
2006 Sauer C, Peters FT, Staack RF, Fritschi G, Maurer HH. New designer drug N-(1-phenylcyclohexyl)-3-ethoxypropanamine (PCEPA): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques. Journal of Mass Spectrometry : Jms. 41: 1014-29. PMID 16817170 DOI: 10.1002/jms.1058  0.171
2005 Beyer J, Peters FT, Maurer HH. Screening procedure for detection of stimulant laxatives and/or their metabolites in human urine using gas chromatography-mass spectrometry after enzymatic cleavage of conjugates and extractive methylation. Therapeutic Drug Monitoring. 27: 151-7. PMID 15795644 DOI: 10.1097/01.ftd.0000150878.36296.04  0.17
2002 Maurer HH, Kratzsch C, Weber AA, Peters FT, Kraemer T. Validated assay for quantification of oxcarbazepine and its active dihydro metabolite 10-hydroxycarbazepine in plasma by atmospheric pressure chemical ionization liquid chromatography/mass spectrometry. Journal of Mass Spectrometry : Jms. 37: 687-92. PMID 12125001 DOI: 10.1002/jms.325  0.17
2015 Martínez-Ramírez JA, Walther G, Peters FT. Studies on drug metabolism by fungi colonizing decomposing human cadavers. Part II: biotransformation of five model drugs by fungi isolated from post-mortem material. Drug Testing and Analysis. 7: 265-79. PMID 24898183 DOI: 10.1002/dta.1669  0.169
2011 Peters FT, Meyer MR. In vitro approaches to studying the metabolism of new psychoactive compounds. Drug Testing and Analysis. 3: 483-95. PMID 21671427 DOI: 10.1002/dta.295  0.168
2005 Peters FT, Samyn N, Lamers CT, Riedel WJ, Kraemer T, de Boeck G, Maurer HH. Drug testing in blood: validated negative-ion chemical ionization gas chromatographic-mass spectrometric assay for enantioselective measurement of the designer drugs MDEA, MDMA, and MDA and its application to samples from a controlled study with MDMA. Clinical Chemistry. 51: 1811-22. PMID 16099938 DOI: 10.1373/clinchem.2005.052746  0.168
2016 Remane D, Wissenbach DK, Peters FT. Recent advances of liquid chromatography-(tandem) mass spectrometry in clinical and forensic toxicology - an update. Clinical Biochemistry. PMID 27452180 DOI: 10.1016/j.clinbiochem.2016.07.010  0.168
2010 Meyer MR, Peters FT, Maurer HH. Automated mass spectral deconvolution and identification system for GC-MS screening for drugs, poisons, and metabolites in urine. Clinical Chemistry. 56: 575-84. PMID 20185625 DOI: 10.1373/clinchem.2009.135517  0.167
2010 Zöllner A, Parr MK, Drăgan CA, Dräs S, Schlörer N, Peters FT, Maurer HH, Schänzer W, Bureik M. CYP21-catalyzed production of the long-term urinary metandienone metabolite 17beta-hydroxymethyl-17 alpha-methyl-18-norandrosta-1,4,13-trien-3-one: a contribution to the fight against doping. Biological Chemistry. 391: 119-27. PMID 19919183 DOI: 10.1515/BC.2010.002  0.165
2002 Maurer HH, Kraemer T, Kratzsch C, Peters FT, Weber AA. Negative ion chemical ionization gas chromatography-mass spectrometry and atmospheric pressure chemical ionization liquid chromatography-mass spectrometry of low-dosed and/or polar drugs in plasma. Therapeutic Drug Monitoring. 24: 117-24. PMID 11805732 DOI: 10.1097/00007691-200202000-00019  0.164
2009 Sauer C, Peters FT, Schwaninger AE, Meyer MR, Maurer HH. Investigations on the cytochrome P450 (CYP) isoenzymes involved in the metabolism of the designer drugs N-(1-phenyl cyclohexyl)-2-ethoxyethanamine and N-(1-phenylcyclohexyl)-2-methoxyethanamine. Biochemical Pharmacology. 77: 444-50. PMID 19022226 DOI: 10.1016/j.bcp.2008.10.024  0.162
2010 Remane D, Meyer MR, Peters FT, Wissenbach DK, Maurer HH. Fast and simple procedure for liquid-liquid extraction of 136 analytes from different drug classes for development of a liquid chromatographic-tandem mass spectrometric quantification method in human blood plasma. Analytical and Bioanalytical Chemistry. 397: 2303-14. PMID 20495906 DOI: 10.1007/s00216-010-3820-7  0.161
2003 Kraemer T, Roditis SK, Peters FT, Maurer HH. Amphetamine concentrations in human urine following single-dose administration of the calcium antagonist prenylamine-studies using fluorescence polarization immunoassay (FPIA) and GC-MS. Journal of Analytical Toxicology. 27: 68-73. PMID 12669999 DOI: 10.1093/JAT/27.2.68  0.16
2014 Peters FT. Recent developments in urinalysis of metabolites of new psychoactive substances using LC-MS. Bioanalysis. 6: 2083-107. PMID 25322784 DOI: 10.4155/bio.14.168  0.16
2004 Kratzsch C, Tenberken O, Peters FT, Weber AA, Kraemer T, Maurer HH. Screening, library-assisted identification and validated quantification of 23 benzodiazepines, flumazenil, zaleplone, zolpidem and zopiclone in plasma by liquid chromatography/mass spectrometry with atmospheric pressure chemical ionization. Journal of Mass Spectrometry : Jms. 39: 856-72. PMID 15329838 DOI: 10.1002/jms.599  0.16
2009 Mueller M, Peters FT, Huestis MA, Ricaurte GA, Maurer HH. Simultaneous liquid chromatographic-electrospray ionization mass spectrometric quantification of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) and its metabolites 3,4-dihydroxymethamphetamine, 4-hydroxy-3-methoxymethamphetamine and 3,4-methylenedioxyamphetamine in squirrel monkey and human plasma after acidic conjugate cleavage. Forensic Science International. 184: 64-8. PMID 19131196 DOI: 10.1016/J.Forsciint.2008.12.002  0.16
2017 Rudolph W, Remane D, Wissenbach DK, Klein C, Barnewitz D, Peters FT. Development and Validation of a UHPLC-HRMS/MS Quantification Method for Hypoglycin A and MCPA-Carnitine in Horse Serum in Cases of Atypical Myopathy. Drug Testing and Analysis. PMID 29148268 DOI: 10.1002/dta.2337  0.159
2009 Peters FT, Bureik M, Maurer HH. Biotechnological synthesis of drug metabolites using human cytochrome P450 isozymes heterologously expressed in fission yeast. Bioanalysis. 1: 821-30. PMID 21083140 DOI: 10.4155/bio.09.53  0.159
2007 Beyer J, Peters FT, Kraemer T, Maurer HH. Detection and validated quantification of nine herbal phenalkylamines and methcathinone in human blood plasma by LC-MS/MS with electrospray ionization. Journal of Mass Spectrometry : Jms. 42: 150-60. PMID 17154352 DOI: 10.1002/jms.1132  0.158
2023 Franke L, Fuczik C, Hubig M, Peters FT, Wissenbach DK. Evaluation of Biochemical Assays and Optimization of LC-MS/MS Analysis for the Detection of Synthetic Urine. Journal of Analytical Toxicology. PMID 37933588 DOI: 10.1093/jat/bkad082  0.157
2007 Peters FT, Dragan CA, Wilde DR, Meyer MR, Zapp J, Bureik M, Maurer HH. Biotechnological synthesis of drug metabolites using human cytochrome P450 2D6 heterologously expressed in fission yeast exemplified for the designer drug metabolite 4'-hydroxymethyl-alpha-pyrrolidinobutyrophenone. Biochemical Pharmacology. 74: 511-20. PMID 17572388 DOI: 10.1016/j.bcp.2007.05.010  0.157
2018 Kluge J, Rentzsch L, Remane D, Peters FT, Wissenbach DK. Systematic investigations of novel validity parameters in urine drug testing and prevalence of urine adulteration in a 2 year cohort. Drug Testing and Analysis. PMID 29956490 DOI: 10.1002/dta.2447  0.157
2009 Meyer MR, Peters FT, Maurer HH. Investigations on the human hepatic cytochrome P450 isozymes involved in the metabolism of 3,4-methylenedioxy-amphetamine (MDA) and benzodioxolyl-butanamine (BDB) enantiomers. Toxicology Letters. 190: 54-60. PMID 19576971 DOI: 10.1016/j.toxlet.2009.06.866  0.157
2019 Rudolph W, Remane D, Wissenbach DK, Peters FT. Comparative study on the metabolism of the ergot alkaloids ergocristine, ergocryptine, ergotamine, and ergovaline in equine and human S9 fractions and equine liver preparations. Xenobiotica; the Fate of Foreign Compounds in Biological Systems. 1-9. PMID 30623698 DOI: 10.1080/00498254.2018.1542187  0.155
2012 Wissenbach DK, Meyer MR, Weber AA, Remane D, Ewald AH, Peters FT, Maurer HH. Towards a universal LC-MS screening procedure - can an LIT LC-MS(n) screening approach and reference library be used on a quadrupole-LIT hybrid instrument? Journal of Mass Spectrometry : Jms. 47: 66-71. PMID 22282091 DOI: 10.1002/jms.2027  0.155
2022 Wille SMR, Desharnais B, Pichini S, Trana AD, Busardò FP, Wissenbach DK, Peters FT. Liquid Chromatography High Resolution Mass Spectrometry in Forensic Toxicology: What Are the Specifics of Method Development, Validation and Quality Assurance for Comprehensive Screening Approaches? Current Pharmaceutical Design. PMID 35619258 DOI: 10.2174/1381612828666220526152259  0.154
2012 Neunzig I, Göhring A, Drăgan CA, Zapp J, Peters FT, Maurer HH, Bureik M. Production and NMR analysis of the human ibuprofen metabolite 3-hydroxyibuprofen. Journal of Biotechnology. 157: 417-20. PMID 22226725 DOI: 10.1016/j.jbiotec.2011.12.016  0.154
2009 Meyer MR, Peters FT, Maurer HH. Stereoselective differences in the cytochrome P450-dependent dealkylation and demethylenation of N-methyl-benzodioxolyl-butanamine (MBDB, Eden) enantiomers. Biochemical Pharmacology. 77: 1725-34. PMID 19428327 DOI: 10.1016/j.bcp.2009.03.001  0.154
2002 Maurer HH, Kratzsch C, Kraemer T, Peters FT, Weber AA. Screening, library-assisted identification and validated quantification of oral antidiabetics of the sulfonylurea-type in plasma by atmospheric pressure chemical ionization liquid chromatography-mass spectrometry. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 773: 63-73. PMID 12015271 DOI: 10.1016/S1570-0232(01)00618-3  0.153
2011 Peters FT. Recent advances of liquid chromatography-(tandem) mass spectrometry in clinical and forensic toxicology. Clinical Biochemistry. 44: 54-65. PMID 20709050 DOI: 10.1016/j.clinbiochem.2010.08.008  0.153
2005 Maurer HH, Peters FT. Toward high-throughput drug screening using mass spectrometry. Therapeutic Drug Monitoring. 27: 686-8. PMID 16404794 DOI: 10.1097/01.ftd.0000180224.19384.f0  0.152
2002 Peters FT, Kraemer T, Maurer HH. Drug testing in blood: validated negative-ion chemical ionization gas chromatographic-mass spectrometric assay for determination of amphetamine and methamphetamine enantiomers and its application to toxicology cases. Clinical Chemistry. 48: 1472-85. PMID 12194924  0.152
2008 Peters FT, Meyer MR, Theobald DS, Maurer HH. Identification of cytochrome P450 enzymes involved in the metabolism of the new designer drug 4'-methyl-alpha-pyrrolidinobutyrophenone. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 36: 163-8. PMID 17962373 DOI: 10.1124/dmd.107.017293  0.151
2011 Neunzig I, Drăgan CA, Widjaja M, Schwaninger AE, Peters FT, Maurer HH, Bureik M. Whole-cell biotransformation assay for investigation of the human drug metabolizing enzyme CYP3A7. Biochimica Et Biophysica Acta. 1814: 161-7. PMID 20637317 DOI: 10.1016/j.bbapap.2010.07.011  0.15
2009 Meyer MR, Peters FT, Maurer HH. The role of human hepatic cytochrome P450 isozymes in the metabolism of racemic 3,4-methylenedioxyethylamphetamine and its single enantiomers. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 37: 1152-6. PMID 19299523 DOI: 10.1124/dmd.108.026203  0.148
2018 Rudolph W, Remane D, Wissenbach DK, Peters FT. Development and validation of an UHPLC-HRMS/MS assay for nine toxic alkaloids from endophyte-infected pasture grasses in horse serum. Journal of Chromatography. A. PMID 29779692 DOI: 10.1016/j.chroma.2018.05.013  0.145
2010 Zöllner A, Buchheit D, Meyer MR, Maurer HH, Peters FT, Bureik M. Production of human phase 1 and 2 metabolites by whole-cell biotransformation with recombinant microbes. Bioanalysis. 2: 1277-90. PMID 21083240 DOI: 10.4155/bio.10.80  0.144
2008 Mueller M, Peters FT, Ricaurte GA, Maurer HH. Liquid chromatographic-electrospray ionization mass spectrometric assay for simultaneous determination of 3,4-methylenedioxymethamphetamine and its metabolites 3,4-methylenedioxyamphetamine, 3,4-dihydroxymethamphetamine, and 4-hydroxy-3-methoxymethamphetamine in rat brain. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 874: 119-24. PMID 18829400 DOI: 10.1016/j.jchromb.2008.09.009  0.14
2007 Beyer J, Peters FT, Kraemer T, Maurer HH. Detection and validated quantification of toxic alkaloids in human blood plasma--comparison of LC-APCI-MS with LC-ESI-MS/MS. Journal of Mass Spectrometry : Jms. 42: 621-33. PMID 17323418 DOI: 10.1002/jms.1191  0.137
2005 Peters FT, Jung J, Kraemer T, Maurer HH. Fast, simple, and validated gas chromatographic-mass spectrometric assay for quantification of drugs relevant to diagnosis of brain death in human blood plasma samples. Therapeutic Drug Monitoring. 27: 334-44. PMID 15905804 DOI: 10.1097/01.ftd.0000158079.53577.46  0.137
2005 Habrdova V, Peters FT, Theobald DS, Maurer HH. Screening for and validated quantification of phenethylamine-type designer drugs and mescaline in human blood plasma by gas chromatography/mass spectrometry. Journal of Mass Spectrometry : Jms. 40: 785-95. PMID 15827969 DOI: 10.1002/jms.853  0.136
2007 Peters FT, Samyn N, Kraemer T, Riedel WJ, Maurer HH. Negative-ion chemical ionization gas chromatography-mass spectrometry assay for enantioselective measurement of amphetamines in oral fluid: application to a controlled study with MDMA and driving under the influence cases. Clinical Chemistry. 53: 702-10. PMID 17332148 DOI: 10.1373/clinchem.2006.081547  0.136
2017 Wille SMR, Coucke W, Baere T, Peters FT. Update of Standard Practices for New Method Validation in Forensic Toxicology. Current Pharmaceutical Design. PMID 28714407 DOI: 10.2174/1381612823666170714154444  0.135
2004 Maurer HH, Tenberken O, Kratzsch C, Weber AA, Peters FT. Screening for library-assisted identification and fully validated quantification of 22 beta-blockers in blood plasma by liquid chromatography-mass spectrometry with atmospheric pressure chemical ionization. Journal of Chromatography. A. 1058: 169-81. PMID 15595665  0.133
2022 Franke L, Peters FT, Wissenbach DK. Long time stability of 35 small endogenous biomolecules in dried urine spotted on various surfaces and environmental conditions. Forensic Science International. 339: 111420. PMID 35985138 DOI: 10.1016/j.forsciint.2022.111420  0.131
2021 Krait S, Wissenbach DK, Peters FT, Scriba GKE. HPLC-MS identification of acid degradation products of dolutegravir. Journal of Pharmaceutical and Biomedical Analysis. 197: 113954. PMID 33601161 DOI: 10.1016/j.jpba.2021.113954  0.131
2007 Peters FT. Stability of analytes in biosamples - an important issue in clinical and forensic toxicology? Analytical and Bioanalytical Chemistry. 388: 1505-19. PMID 17429615 DOI: 10.1007/s00216-007-1267-2  0.13
2009 Mueller M, Kolbrich EA, Peters FT, Maurer HH, McCann UD, Huestis MA, Ricaurte GA. Direct comparison of (+/-) 3,4-methylenedioxymethamphetamine ("ecstasy") disposition and metabolism in squirrel monkeys and humans. Therapeutic Drug Monitoring. 31: 367-73. PMID 19417716 DOI: 10.1097/Ftd.0B013E3181A4F6C2  0.13
2012 Peters FT, Remane D. Aspects of matrix effects in applications of liquid chromatography-mass spectrometry to forensic and clinical toxicology--a review. Analytical and Bioanalytical Chemistry. 403: 2155-72. PMID 22549818 DOI: 10.1007/s00216-012-6035-2  0.129
2023 Peters FT, Wissenbach D. Current state-of-the-art approaches for mass spectrometry in clinical toxicology: an overview. Expert Opinion On Drug Metabolism & Toxicology. 1-14. PMID 37615282 DOI: 10.1080/17425255.2023.2252324  0.128
2008 Meyer MR, Peters FT, Maurer HH. The role of human hepatic cytochrome P450 isozymes in the metabolism of racemic 3,4-methylenedioxy-methamphetamine and its enantiomers. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 36: 2345-54. PMID 18725511 DOI: 10.1124/dmd.108.021543  0.126
2013 Neunzig I, Widjaja M, Peters FT, Maurer HH, Hehn A, Bourgaud F, Bureik M. Coexpression of CPR from various origins enhances biotransformation activity of human CYPs in S. pombe. Applied Biochemistry and Biotechnology. 170: 1751-66. PMID 23737303 DOI: 10.1007/s12010-013-0303-2  0.126
2024 Stammer VC, Wissenbach DK, Peters FT. False-positive MDA findings in HRMS-based screening of putrefied postmortem blood samples-Identification of the interference as N-acetyltyramine. Journal of Analytical Toxicology. PMID 38502107 DOI: 10.1093/jat/bkae015  0.126
2007 von Mach MA, Weber C, Meyer MR, Weilemann LS, Maurer HH, Peters FT. Comparison of urinary on-site immunoassay screening and gas chromatography-mass spectrometry results of 111 patients with suspected poisoning presenting at an emergency department. Therapeutic Drug Monitoring. 29: 27-39. PMID 17304147 DOI: 10.1097/FTD.0b013e31802bb2aa  0.126
2016 Martínez-Ramírez JA, Strien J, Walther G, Peters FT. Search for fungi-specific metabolites of four model drugs in postmortem blood as potential indicators of postmortem fungal metabolism. Forensic Science International. 262: 173-178. PMID 27022860 DOI: 10.1016/j.forsciint.2016.03.006  0.124
2019 Rudolph W, Remane D, Wissenbach DK, Peters FT. Liquid chromatography-mass spectrometry-based determination of ergocristine, ergocryptine, ergotamine, ergovaline, hypoglycin A, lolitrem B, methylene cyclopropyl acetic acid carnitine, N-acetylloline, N-formylloline, paxilline, and peramine in equine hair. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 1117: 127-135. PMID 31009898 DOI: 10.1016/j.jchromb.2019.04.016  0.123
2004 Kraemer T, Pflugmann T, Bossmann M, Kneller NM, Peters FT, Paul LD, Springer D, Staack RF, Maurer HH. Fenproporex N-dealkylation to amphetamine--enantioselective in vitro studies in human liver microsomes as well as enantioselective in vivo studies in Wistar and Dark Agouti rats. Biochemical Pharmacology. 68: 947-57. PMID 15294457 DOI: 10.1016/j.bcp.2004.05.009  0.121
2010 Peters FT, Martinez-Ramirez JA. Analytical toxicology of emerging drugs of abuse. Therapeutic Drug Monitoring. 32: 532-9. PMID 20814349 DOI: 10.1097/FTD.0b013e3181f33411  0.12
2012 Meyer MR, Peters FT. Analytical toxicology of emerging drugs of abuse--an update. Therapeutic Drug Monitoring. 34: 615-21. PMID 23131695 DOI: 10.1097/FTD.0b013e31826d0915  0.12
2007 Peters FT, Maurer HH. Systematic comparison of bias and precision data obtained with multiple-point and one-point calibration in six validated multianalyte assays for quantification of drugs in human plasma. Analytical Chemistry. 79: 4967-76. PMID 17518444 DOI: 10.1021/ac070054s  0.119
2009 Song JH, O'Brien P, Peters FH. Optimal laser welding assembly sequences for butterfly laser module packages. Optics Express. 17: 16406-14. PMID 19770854  0.117
2008 Sauer C, Peters FT, Schwaninger AE, Meyer MR, Maurer HH. Identification of cytochrome P450 enzymes involved in the metabolism of the designer drugs N-(1-phenylcyclohexyl)-3-ethoxypropanamine and N-(1-phenylcyclohexyl)-3-methoxypropanamine. Chemical Research in Toxicology. 21: 1949-55. PMID 18778087 DOI: 10.1021/tx8001302  0.116
2011 Sauer C, Hoffmann K, Schimmel U, Peters FT. Acute poisoning involving the pyrrolidinophenone-type designer drug 4'-methyl-alpha-pyrrolidinohexanophenone (MPHP). Forensic Science International. 208: e20-5. PMID 21444164 DOI: 10.1016/j.forsciint.2011.02.026  0.114
2007 Peters FT, Drummer OH, Musshoff F. Validation of new methods. Forensic Science International. 165: 216-24. PMID 16781833 DOI: 10.1016/j.forsciint.2006.05.021  0.112
2020 Jia Z, Yang H, Perrott AH, Wang H, Peters FH. Study on the proximity of QWI in InP-based AlGaInAs MQWs using the IFVD method and its application in single frequency teardrop laser diodes. Optics Express. 28: 31904-31913. PMID 33115154 DOI: 10.1364/OE.398118  0.112
2024 Städtler M, Wissenbach D, Wissenbach DK, Franke L, Pastuschek J, Schleussner E, Allison B, Peters FT, Groten T. A liquid chromatographic-mass spectrometric procedure for analysis of pentaerythrityl tetranitrate metabolites - Development, validation and application to ovine serum and human plasma samples. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 1234: 124028. PMID 38330519 DOI: 10.1016/j.jchromb.2024.124028  0.11
2012 Neunzig I, Widjaja M, Drăgan CA, Peters FT, Maurer HH, Bureik M. Engineering of human CYP3A enzymes by combination of activating polymorphic variants. Applied Biochemistry and Biotechnology. 168: 785-96. PMID 22899011 DOI: 10.1007/s12010-012-9819-0  0.109
2009 Zöllner A, Dragan CA, Pistorius D, Müller R, Bode HB, Peters FT, Maurer HH, Bureik M. Human CYP4Z1 catalyzes the in-chain hydroxylation of lauric acid and myristic acid. Biological Chemistry. 390: 313-7. PMID 19090726 DOI: 10.1515/Bc.2009.030  0.108
2009 Mueller M, Kolbrich-Spargo EA, Peters FT, Huestis MA, Ricaurte GA, Maurer HH. Hydrolysis of 3,4-methylenedioxymethamphetamine (MDMA) metabolite conjugates in human, squirrel monkey, and rat plasma. Analytical and Bioanalytical Chemistry. 393: 1607-17. PMID 19183967 DOI: 10.1007/S00216-009-2607-1  0.104
2001 Brusa L, Bianchi A, Fruttuoso G, Manfredini A, Oriolo F, Carelli MD, Kendig RP, Peters FE. Experimental investigation of mixing phenomena inside a concrete containment cooled by an innovative passive system Nuclear Technology. 133: 63-76.  0.103
2016 Yang H, Yang M, Morrissey PE, Lu D, Pan BW, Zhao L, Corbett B, Peters FH. Three-coherent-output narrow-linewidth and tunable single frequency 1x2 multi-mode-interferometer laser diode. Optics Express. 24: 5846-5854. PMID 27136781  0.097
2004 Rieger K, Scholer A, Arnet I, Peters FT, Maurer HH, Walter-Sack I, Haefeli WE, Martin-Facklam M. High prevalence of unknown co-medication in hospitalised patients European Journal of Clinical Pharmacology. 60: 363-368. PMID 15197522 DOI: 10.1007/s00228-004-0784-6  0.096
2012 Carow F, Rieger K, Walter-Sack I, Meyer MR, Peters FT, Maurer HH, Haefeli WE. Objective assessment of nonadherence and unknown co-medication in hospitalized patients. European Journal of Clinical Pharmacology. 68: 1191-9. PMID 22354152 DOI: 10.1007/s00228-012-1229-2  0.096
2011 Drăgan CA, Peters FT, Bour P, Schwaninger AE, Schaan SM, Neunzig I, Widjaja M, Zapp J, Kraemer T, Maurer HH, Bureik M. Convenient gram-scale metabolite synthesis by engineered fission yeast strains expressing functional human P450 systems. Applied Biochemistry and Biotechnology. 163: 965-80. PMID 20927605 DOI: 10.1007/s12010-010-9100-3  0.095
2013 Martínez-Ramírez JA, Strien J, Sanft J, Mall G, Walther G, Peters FT. Studies on drug metabolism by fungi colonizing decomposing human cadavers. Part I: DNA sequence-based identification of fungi isolated from postmortem material. Analytical and Bioanalytical Chemistry. 405: 8443-50. PMID 23954943 DOI: 10.1007/s00216-013-7250-1  0.089
1998 Salisbury EJ, Peters FE. The impact of surface errors on fixtured workpiece location and orientation Technical Paper - Society of Manufacturing Engineers. Ms. 98.  0.088
2023 McCarthy J, O'Sullivan D, Shayesteh M, Dernaika M, Peters FH, Kelleher B. Tunable, coherent optical comb source via on-chip bidirectional coupling. Optics Letters. 48: 4137-4140. PMID 37527137 DOI: 10.1364/OL.492230  0.088
2009 Mueller M, Yuan J, Felim A, Neudörffer A, Peters FT, Maurer HH, McCann UD, Largeron M, Ricaurte GA. Further studies on the role of metabolites in (+/-)-3,4-methylenedioxymethamphetamine-induced serotonergic neurotoxicity. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 37: 2079-86. PMID 19628751 DOI: 10.1124/dmd.109.028340  0.087
2023 McCarthy J, Peters FH. On-chip gain switched frequency comb generation using a two sectioned single cavity laser without additional optical injection. Optics Express. 31: 29619-29626. PMID 37710758 DOI: 10.1364/OE.500300  0.086
2018 Dubois FM, Seifikar M, Perrott AH, Peters FH. Modeling mutually coupled non-identical semiconductor lasers on photonic integrated circuits. Applied Optics. 57: E154-E162. PMID 30117851  0.085
2017 Peters FT, Wissenbach DK, Busardò FP, Marchei E, Pichini S. Method development in Forensic Toxicology. Current Pharmaceutical Design. PMID 28641530 DOI: 10.2174/1381612823666170622113331  0.083
2017 Kelly NP, Caro L, Dernaika M, Peters FH. Regrowth-free integration of injection locked slotted laser with an electroabsorption modulator. Optics Express. 25: 4054-4060. PMID 28241613  0.083
2011 Lu Q, Guo W, Nawrocka M, Abdullaev A, Daunt C, O'Callaghan J, Lynch M, Weldon V, Peters F, Donegan JF. Single mode lasers based on slots suitable for photonic integration. Optics Express. 19: B140-5. PMID 22274010  0.081
2017 Busardo FP, Pichini S, Peters FT. Editorial: Advances and Future Developments in Forensic Toxicology: From Standard Practices to New Psychoactive Substances. Current Pharmaceutical Design. PMID 29237370 DOI: 10.2174/1381612824666171214101337  0.081
2013 Hardis R, Jessop JLP, Peters FE, Kessler MR. Cure kinetics characterization and monitoring of an epoxy resin using DSC, Raman spectroscopy, and DEA Composites Part a: Applied Science and Manufacturing. 49: 100-108. DOI: 10.1016/j.compositesa.2013.01.021  0.08
2008 Mueller M, Peters FT, Maurer HH, McCann UD, Ricaurte GA. Nonlinear pharmacokinetics of (+/-)3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") and its major metabolites in squirrel monkeys at plasma concentrations of MDMA that develop after typical psychoactive doses. The Journal of Pharmacology and Experimental Therapeutics. 327: 38-44. PMID 18591215 DOI: 10.1124/jpet.108.141366  0.077
2017 Gröger M, Dinger J, Kiehntopf M, Peters FT, Rauen U, Mosig AS. Preservation of Cell Structure, Metabolism, and Biotransformation Activity of Liver-On-Chip Organ Models by Hypothermic Storage. Advanced Healthcare Materials. PMID 28960916 DOI: 10.1002/adhm.201700616  0.076
2019 Chandran S, Ruth AA, Martin EP, Alexander JK, Peters FH, Anandarajah PM. Off-Axis Cavity-Enhanced Absorption Spectroscopy of NH in Air Using a Gain-Switched Frequency Comb at 1.514 μm. Sensors (Basel, Switzerland). 19. PMID 31795087 DOI: 10.3390/s19235217  0.076
1995 Brockie AJ, Carlson RW, Bueter TW, Conway LE, Hochreiter LE, Loftus MJ, Peters FE, Piplica EJ, Yeh HC, Incalcateria P, Kropp CA. Analysis of the automatic depressurization system (ADS) tests for the AP600 design American Society of Mechanical Engineers, Nuclear Engineering Division (Publication) NE. 2: 119-132.  0.076
2020 Lingnau B, Perrott AH, Dernaika M, Caro L, Peters FH, Kelleher B. Dynamics of on-chip asymmetrically coupled semiconductor lasers. Optics Letters. 45: 2223-2226. PMID 32287199 DOI: 10.1364/OL.390401  0.073
2011 Peters FT, Maurer HH, Musshoff F. Forensic toxicology. Analytical and Bioanalytical Chemistry. 400: 7-8. PMID 21331493 DOI: 10.1007/s00216-011-4711-2  0.07
2004 Jackman JK, Olafsson S, Peters FE, Ryan SM, Saunders K. Integrated curriculum to improve engineering problem solving Iie Annual Conference and Exhibition 2004. 249-254.  0.068
2010 Frank MC, Peters FE, Karthikeyan R. Additive/subtractive rapid pattern manufacturing for casting patterns and injection mold tooling 21st Annual International Solid Freeform Fabrication Symposium - An Additive Manufacturing Conference, Sff 2010. 242-255.  0.066
2015 Rennert K, Steinborn S, Gröger M, Ungerböck B, Jank AM, Ehgartner J, Nietzsche S, Dinger J, Kiehntopf M, Funke H, Peters FT, Lupp A, Gärtner C, Mayr T, Bauer M, et al. A microfluidically perfused three dimensional human liver model. Biomaterials. 71: 119-31. PMID 26322723 DOI: 10.1016/J.Biomaterials.2015.08.043  0.066
2020 Alexander JK, Caro L, Dernaika M, Duggan SP, Yang H, Chandran S, Martin EP, Ruth AA, Anandarajah PM, Peters FH. Integrated dual optical frequency comb source. Optics Express. 28: 16900-16906. PMID 32549503 DOI: 10.1364/OE.384706  0.064
2020 Lingnau B, Shortiss K, Dubois F, Peters FH, Kelleher B. Universal generation of devil's staircases near Hopf bifurcations via modulated forcing of nonlinear systems. Physical Review. E. 102: 030201. PMID 33075975 DOI: 10.1103/PhysRevE.102.030201  0.064
1997 Carelli MD, Cavicchia V, Fiorino E, Kendig RP, Peters FE, Valisi M. Experimental investigation of hydrogen mixing in advanced nuclear reactor containments International Conference On Nuclear Engineering, Proceedings, Icone. 122-123.  0.063
2016 Cooney K, Peters FH. Analysis of multimode interferometers. Optics Express. 24: 22481-22515. PMID 27828321  0.063
2019 Shortiss K, Lingnau B, Dubois F, Kelleher B, Peters FH. Harmonic frequency locking and tuning of comb frequency spacing through optical injection. Optics Express. 27: 36976-36989. PMID 31873468 DOI: 10.1364/OE.27.036976  0.06
2009 Frank MC, Peters FE, Luo X, Meng F, Petrzelka J. A hybrid rapid pattern manufacturing system for sand castings 20th Annual International Solid Freeform Fabrication Symposium, Sff 2009. 35-46.  0.06
2018 Seifikar M, Amann A, Peters FH. Dynamics of two identical mutually delay-coupled semiconductor lasers in photonic integrated circuits. Applied Optics. 57: E37-E44. PMID 30117919  0.059
2016 Gröger M, Rennert K, Giszas B, Weiß E, Dinger J, Funke H, Kiehntopf M, Peters FT, Lupp A, Bauer M, Claus RA, Huber O, Mosig AS. Monocyte-induced recovery of inflammation-associated hepatocellular dysfunction in a biochip-based human liver model. Scientific Reports. 6: 21868. PMID 26902749 DOI: 10.1038/srep21868  0.057
2017 Peters F, Ellermann I, Steinbicker AU. Intravenous Iron for Treatment of Anemia in the 3 Perisurgical Phases: A Review and Analysis of the Current Literature. Anesthesia and Analgesia. PMID 29261547 DOI: 10.1213/ANE.0000000000002591  0.056
2009 Fleissner MR, Brustad EM, Kálai T, Altenbach C, Cascio D, Peters FB, Hideg K, Peuker S, Schultz PG, Hubbell WL. Site-directed spin labeling of a genetically encoded unnatural amino acid. Proceedings of the National Academy of Sciences of the United States of America. 106: 21637-42. PMID 19995976 DOI: 10.1073/Pnas.0912009106  0.055
2012 Peters FM, Greeff R, Goldstein N, Frey CT. Improving acetabular cup orientation in total hip arthroplasty by using smartphone technology. The Journal of Arthroplasty. 27: 1324-30. PMID 22245126 DOI: 10.1016/j.arth.2011.11.014  0.055
2013 Gity F, Daly A, Snyder B, Peters FH, Hayes J, Colinge C, Morrison AP, Corbett B. Ge/Si heterojunction photodiodes fabricated by low temperature wafer bonding. Optics Express. 21: 17309-14. PMID 23938577 DOI: 10.1364/OE.21.017309  0.054
1956 Peters FE, Wills PA. Dried breadfruit [31] Nature. 178: 1252. DOI: 10.1038/1781252a0  0.052
2010 Groff D, Chen PR, Peters FB, Schultz PG. A genetically encoded epsilon-N-methyl lysine in mammalian cells. Chembiochem : a European Journal of Chemical Biology. 11: 1066-8. PMID 20422671 DOI: 10.1002/Cbic.200900690  0.052
2015 Walter D, van Boeckel PG, Groenen MJ, Weusten BL, Witteman BJ, Tan G, Brink MA, Nicolai J, Tan AC, Alderliesten J, Venneman NG, Laleman W, Jansen JM, Bodelier A, Wolters FL, ... ... Peters FT, et al. Cost Efficacy of Metal Stents for Palliation of Extrahepatic Bile Duct Obstruction in a Randomized Controlled Trial. Gastroenterology. 149: 130-8. PMID 25790742 DOI: 10.1053/j.gastro.2015.03.012  0.051
1953 Peters FE. The Chemical Composition of New Hebridean Human Milk British Journal of Nutrition. 7: 208-211. PMID 13081934 DOI: 10.1079/BJN19530025  0.051
2012 Cotter W, Goulding D, Roycroft B, O'Callaghan J, Corbett B, Peters FH. Investigation of active filter using injection-locked slotted Fabry-Perot semiconductor laser. Applied Optics. 51: 7357-61. PMID 23089792 DOI: 10.1364/AO.51.007357  0.051
2010 Michiels M, Mellema M, Peters FP. [Haemorrhages due to vitamin C deficiency. Scurvy in the 21st century]. Nederlands Tijdschrift Voor Geneeskunde. 154: A1638. PMID 20699018  0.05
2003 Norgauer J, Dichmann S, Peters F, Mockenhaupt M, Schraufst tter I, Herouy Y. Tumor necrosis factor alpha induces upregulation of CXC-chemokine receptor type II expression and magnifies the proliferative activity of CXC-chemokines in human melanocytes. European Journal of Dermatology : Ejd. 13: 124-9. PMID 12695126  0.049
2009 Peters FB, Brock A, Wang J, Schultz PG. Photocleavage of the polypeptide backbone by 2-nitrophenylalanine. Chemistry & Biology. 16: 148-52. PMID 19246005 DOI: 10.1016/J.Chembiol.2009.01.013  0.048
2004 Ryan SM, Jackman JK, Peters FE, Ólafsson S, Huba ME. The engineering learning portal for problem solving: Experience in a large engineering economy class Engineering Economist. 49: 1-19. DOI: 10.1080/00137910490432575  0.048
2013 Aarts MJ, Peters FP, Mandigers CM, Dercksen MW, Stouthard JM, Nortier HJ, van Laarhoven HW, van Warmerdam LJ, van de Wouw AJ, Jacobs EM, Mattijssen V, van der Rijt CC, Smilde TJ, van der Velden AW, Temizkan M, et al. Primary granulocyte colony-stimulating factor prophylaxis during the first two cycles only or throughout all chemotherapy cycles in patients with breast cancer at risk for febrile neutropenia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 4290-6. PMID 23630211 DOI: 10.1200/JCO.2012.44.6229  0.047
2013 Aarts MJ, Grutters JP, Peters FP, Mandigers CM, Dercksen MW, Stouthard JM, Nortier HJ, van Laarhoven HW, van Warmerdam LJ, van de Wouw AJ, Jacobs EM, Mattijssen V, van der Rijt CC, Smilde TJ, van der Velden AW, et al. Cost effectiveness of primary pegfilgrastim prophylaxis in patients with breast cancer at risk of febrile neutropenia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 4283-9. PMID 24166522 DOI: 10.1200/JCO.2012.48.3644  0.045
2018 Gröger M, Rennert K, Giszas B, Weiß E, Dinger J, Funke H, Kiehntopf M, Peters FT, Lupp A, Bauer M, Claus RA, Huber O, Mosig AS. Corrigendum: Monocyte-induced recovery of inflammation-associated hepatocellular dysfunction in a biochip-based human liver model. Scientific Reports. 8: 46988. PMID 29756606 DOI: 10.1038/srep46988  0.045
2003 Mockenhaupt M, Peters F, Schwenk-Davoine I, Herouy Y, Schraufstätter I, Elsner P, Norgauer J. Evidence of involvement of CXC-chemokines in proliferation of cultivated human melanocytes. International Journal of Molecular Medicine. 12: 597-601. PMID 12964041  0.044
2020 Verhaart SL, Abu-Ghanem Y, Mulder SF, Oosting S, Van Der Veldt A, Osanto S, Aarts MJB, Houtsma D, Peters FPJ, Groenewegen G, Van Herpen CML, Pronk LM, Tascilar M, Hamberg P, Los M, et al. Real-world Data of Nivolumab for Patients With Advanced Renal Cell Carcinoma in the Netherlands: An Analysis of Toxicity, Efficacy, and Predictive Markers. Clinical Genitourinary Cancer. PMID 33317946 DOI: 10.1016/j.clgc.2020.10.003  0.044
2023 Rahman T, Peters F, Wan LQ. Cell jamming regulates epithelial chiral morphogenesis. Journal of Biomechanics. 147: 111435. PMID 36641827 DOI: 10.1016/j.jbiomech.2023.111435  0.044
2014 Xiao H, Peters FB, Yang PY, Reed S, Chittuluru JR, Schultz PG. Genetic incorporation of histidine derivatives using an engineered pyrrolysyl-tRNA synthetase. Acs Chemical Biology. 9: 1092-6. PMID 24506189 DOI: 10.1021/Cb500032C  0.043
2013 van Oijen B, Janknegt R, de Wit H, Peters F, Schouten H, van der Kuy H. Medication surveillance on intravenous cytotoxic agents: a retrospective study. International Journal of Clinical Pharmacy. 35: 554-9. PMID 23585184 DOI: 10.1007/s11096-012-9723-2  0.043
1998 Müller A, Krickemeyer E, Bögge H, Schmidtmann M, Peters F. Organizational Forms of Matter: An Inorganic Super Fullerene and Keplerate Based on Molybdenum Oxide. Angewandte Chemie (International Ed. in English). 37: 3359-3363. PMID 29711296 DOI: 10.1002/(Sici)1521-3773(19981231)37:24<3359::Aid-Anie3359>3.0.Co;2-J  0.042
2012 van Baardwijk A, Reymen B, Wanders S, Borger J, Ollers M, Dingemans AM, Bootsma G, Geraedts W, Pitz C, Lunde R, Peters F, Lambin P, De Ruysscher D. Mature results of a phase II trial on individualised accelerated radiotherapy based on normal tissue constraints in concurrent chemo-radiation for stage III non-small cell lung cancer. European Journal of Cancer (Oxford, England : 1990). 48: 2339-46. PMID 22608261 DOI: 10.1016/J.Ejca.2012.04.014  0.04
2017 Aarts MJ, Vriens BE, de Boer M, Peters FP, Mandigers CM, Dercksen MW, Stouthard JM, Tol J, van Warmerdam LJ, van de Wouw AJ, Jacobs EM, van der Rijt CCD, Smilde TJ, van der Velden AW, Peer N, et al. Neutrophil Recovery in Breast Cancer Patients Receiving Docetaxel-Containing Chemotherapy with and without Granulocyte Colony-Stimulating Factor Prophylaxis. Oncology. PMID 28848182 DOI: 10.1159/000479067  0.04
2016 Westgeest HM, Uyl-de Groot CA, van Moorselaar RJA, de Wit R, van den Bergh ACM, Coenen JLLM, Beerlage HP, Hendriks MP, Bos MMEM, van den Berg P, van de Wouw AJ, Spermon R, Boerma MO, Geenen MM, Tick LW, ... ... Peters FPJ, et al. Differences in Trial and Real-world Populations in the Dutch Castration-resistant Prostate Cancer Registry. European Urology Focus. PMID 28753794 DOI: 10.1016/j.euf.2016.09.008  0.039
2013 Sternberg CN, Skoneczna IA, Castellano D, Theodore C, Blais N, Voog E, Bellmunt J, Peters F, Le-Guennec S, Cerbone L, Risse ML, MacHiels JP. Larotaxel with cisplatin in the first-line treatment of locally advanced/metastatic urothelial tract or bladder cancer: A randomized, active-controlled, phase iii trial (CILAB) Oncology (Switzerland). 85: 208-215. PMID 24080920 DOI: 10.1159/000354085  0.039
2018 Peters F, Eveslage M, Gallitz I, Wempe C, Meybohm P, Van Aken HK, Steinbicker AU. Post-Operative Iron Carboxymaltose May Have an Effect on Haemoglobin Levels in Cardiothoracic Surgical Patients on the ICU - an Observational Pilot Study about Anaemia Treatment with Intravenous Iron. Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie. 45: 42-46. PMID 29593459 DOI: 10.1159/000481143  0.039
2016 Cirkel GA, Hamberg P, Sleijfer S, Loosveld OJ, Dercksen MW, Los M, Polee MB, van den Berkmortel F, Aarts MJ, Beerepoot LV, Groenewegen G, Lolkema MP, Tascilar M, Portielje JE, Peters FP, et al. Alternating Treatment With Pazopanib and Everolimus vs Continuous Pazopanib to Delay Disease Progression in Patients With Metastatic Clear Cell Renal Cell Cancer: The ROPETAR Randomized Clinical Trial. Jama Oncology. PMID 27918762 DOI: 10.1001/jamaoncol.2016.5202  0.038
2013 Lobbezoo DJ, van Kampen RJ, Voogd AC, Dercksen MW, van den Berkmortel F, Smilde TJ, van de Wouw AJ, Peters FP, van Riel JM, Peters NA, de Boer M, Borm GF, Tjan-Heijnen VC. Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcome. Breast Cancer Research and Treatment. 141: 507-14. PMID 24104881 DOI: 10.1007/s10549-013-2711-y  0.037
2014 Kusters PJ, Keulen ET, Peters FP. Duodenal perforation following bile duct endoprosthesis placement. Endoscopy. 46: E646-7. PMID 25526406 DOI: 10.1055/s-0034-1390849  0.035
2014 Kessel C, Nandakumar KS, Peters FB, Gauba V, Schultz PG, Holmdahl R. A single functional group substitution in c5a breaks B cell and T cell tolerance and protects against experimental arthritis. Arthritis & Rheumatology (Hoboken, N.J.). 66: 610-21. PMID 24574221 DOI: 10.1002/Art.38237  0.034
2018 Sheehan RN, Guina M, Viheriälä J, Isoaho R, Harjanne M, Azarello F, Yang M, Malacarne A, Aalto T, Peters FH. Data transmission at 1300 nm using optical interposer comprising hybrid integrated silicon waveguide and dilute nitride electroabsorption modulator. Optics Express. 26: 34336-34345. PMID 30650857 DOI: 10.1364/OE.26.034336  0.034
2021 Westermann I, Gastine S, Müller C, Rudolph W, Peters F, Bloos F, Pletz M, Hagel S. Population pharmacokinetics and probability of target attainment in patients with sepsis under renal replacement therapy receiving continuous infusion of meropenem: sustained low-efficiency dialysis (SLED) and continuous veno-venous haemodialysis (CVVHD). British Journal of Clinical Pharmacology. PMID 33818823 DOI: 10.1111/bcp.14846  0.033
2019 Kuppen MCP, Westgeest HM, van den Eertwegh AJM, Coenen JLLM, van Moorselaar RJA, van den Berg P, Geenen MM, Mehra N, Hendriks MP, Lampe MI, van de Luijtgaarden ACM, Peters FPJ, Roeleveld TA, Smilde TJ, de Wit R, et al. Health-related Quality of Life and Pain in a Real-world Castration-resistant Prostate Cancer Population: Results From the PRO-CAPRI Study in the Netherlands. Clinical Genitourinary Cancer. PMID 31883940 DOI: 10.1016/j.clgc.2019.11.015  0.031
2018 Slagter AE, Jansen EPM, van Laarhoven HWM, van Sandick JW, van Grieken NCT, Sikorska K, Cats A, Muller-Timmermans P, Hulshof MCCM, Boot H, Los M, Beerepoot LV, Peters FPJ, Hospers GAP, van Etten B, et al. CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer. Bmc Cancer. 18: 877. PMID 30200910 DOI: 10.1186/S12885-018-4770-2  0.031
1977 Madsen HF, Potter SA, Peters FE. Pest management: Control of archips argyrospilus and archips rosanus (lepidoptera: Tortricidae) on apple The Canadian Entomologist. 109: 171-174. DOI: 10.4039/Ent109171-2  0.027
2020 Hartter I, Remane D, Rabe C, Wissenbach DK, Peters FT, Eyer F. Surviving chlormequat poisoning - pharmacokinetics and the role of atropine. Clinical Toxicology (Philadelphia, Pa.). 1-2. PMID 32336166 DOI: 10.1080/15563650.2020.1758326  0.027
2011 Peters FE. Jesus and Muhammad: Parallel Tracks, Parallel Lives Jesus and Muhammad: Parallel Tracks, Parallel Lives. 1-248. DOI: 10.1093/acprof:oso/9780199747467.001.0001  0.02
2016 Gerostamoulos D, Elliott S, Walls HC, Peters FT, Lynch M, Drummer OH. To Measure or Not to Measure? That Is the NPS Question. Journal of Analytical Toxicology. PMID 26977105 DOI: 10.1093/jat/bkw013  0.02
1968 Kendall CE, Peters FE. Particulate matter in injectables Bibliotheca Haematologica. 29: 990-994. PMID 5728143  0.019
1969 Peters FE. And a library was born Journal of the American Podiatry Association. 59: 196-198. PMID 5769699  0.019
2010 Fleissner MR, Brustad EM, Kálai T, Altenbach C, Cascio D, Peters FB, Hideg K, Peuker S, Schultz PG, Hubbell WL. Site-directed spin labeling of a genetically encoded unnatural amino acid (Proceedings of the National Academy of Sciences of the United States of America (2009) 106, 51 (21637-21642)) Proceedings of the National Academy of Sciences of the United States of America. 107: 5693. DOI: 10.1073/Pnas.1000908107  0.018
2014 Frank MC, Zhu S, Peters FE. Automated composite fabric layup for wind turbine blades Camx 2014 - Composites and Advanced Materials Expo: Combined Strength. Unsurpassed Innovation. 0.018
1949 BOLLIGER A, PETERS FE. Pentoses in hair The Australian Journal of Science. 11: 175. PMID 18141655  0.017
1996 Peters FE. Jesus and Muhammad: A historian's reflections Muslim World. 86: 334-341.  0.017
2006 Diller R, Jakober R, Schumann C, Peters F, Klare JP, Engelhard M. The trans-cis isomerization reaction dynamics in sensory rhodopsin II by femtosecond time-resolved midinfrared spectroscopy: chromophore and protein dynamics. Biopolymers. 82: 358-62. PMID 16475156 DOI: 10.1002/bip.20475  0.016
2012 Julka A, Vranceanu AM, Shah AS, Peters F, Ring D. Predictors of pain during and the day after corticosteroid injection for idiopathic trigger finger. The Journal of Hand Surgery. 37: 237-42. PMID 22192164 DOI: 10.1016/j.jhsa.2011.10.055  0.016
1959 Peters FE, Dodge JW. Changes in pH and temperature in poultry breast muscles at slaughter Nature. 183: 687. PMID 13632837 DOI: 10.1038/183687a0  0.014
1966 Vessey I, Kendall CE, Peters FE. Particulate matter in intravenous fluids Medical Journal of Australia. 1: 293-294. PMID 5906943  0.013
2010 Peters FE. The children of Abraham: Judaism, Christianity, Islam: A new edition The Children of Abraham: Judaism, Christianity, Islam: a New Edition 0.011
1959 Peters FE. La composition chimique des aliments du Pacifique Sud Qualitas Plantarum Et Materiae Vegetabiles. 5: 313-343. DOI: 10.1007/BF01099752  0.011
1991 Peters FE. Chicken DOPA Trends in Food Science and Technology. 2: 44. DOI: 10.1016/0924-2244(91)90615-P  0.011
1998 Müller A, Peters F, Pope MT, Gatteschi D. Polyoxometalates: Very Large Clusters-Nanoscale Magnets. Chemical Reviews. 98: 239-272. PMID 11851505 DOI: 10.1021/Cr9603946  0.01
1965 Peters FE. PARTICLES IN INTRAVENOUS FLUIDS The Lancet. 286: 851.  0.01
Hide low-probability matches.